RU486 Induces Pro-Apoptotic Endoplasmic Reticulum Stress Through the Induction of CHOP Expression by Enhancing C/EBPδ Expression in Human Renal Carcinoma Caki Cells

Journal of Cellular Biochemistry

Volumn 117, Issue 2, 2016, Pages 361-369

  Jang, Ji Hoon ^a   Min, Kyoung Jin ^a   Kim, Shin ^a   Park, Jong Wook ^a   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

Author keywords

APOPTOSIS; C EBP ; CHOP; ER STRESS; RU486

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; COMPLEMENTARY DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; CEBPD PROTEIN, HUMAN; DDIT3 PROTEIN, HUMAN; DNA BINDING PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; X BOX BINDING PROTEIN 1; XBP1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BINDING SITE; CARCINOMA CELL LINE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; RNA SPLICING; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CARCINOMA, RENAL CELL; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MIFEPRISTONE; PROMOTER REGIONS, GENETIC; REGULATORY FACTOR X TRANSCRIPTION FACTORS; RNA SPLICING; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; X-BOX BINDING PROTEIN 1;

EID: 84970938057     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25278     Document Type: Article

References (32)

1. Baulieu EE,. 1989. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 245: 1351-1357.
2. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E,. 1997. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GA DD153. J Biol Chem 272: 22173-22181.
3. Bruhat A, Jousse C, Carraro V, Reimold AM, Ferrara M, Fafournoux P,. 2000. Amino acids control mammalian gene transcription: Activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter. Mol Cell Biol 20: 7192-7204.
4. Bruhat A, Jousse C, Fafournoux P,. 1999. Amino acid limitation regulates gene expression. Proc Nutr Soc 58: 625-632.
5. Bruhat A, Jousse C, Wang XZ, Ron D, Ferrara M, Fafournoux P,. 1997. Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels. J Biol Chem 272: 17588-17593.
6. Chen YJ, Tan BC, Cheng YY, Chen JS, Lee SC,. 2010. Differential regulation of CHOP translation by phosphorylated eIF4E under stress conditions. Nucleic Acids Res 38: 764-777.
7. El Etreby MF, Liang Y, Lewis RW,. 2000. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. The Prostate 43: 31-42.
8. Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ,. 1999. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 339 (Pt 1): 135-141.
9. Gaddy VT, Barrett JT, Delk JN, Kallab AM, Porter AG, Schoenlein PV,. 2004. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells. Clin Cancer Res 10: 5215-5225.
10. Gately DP, Jones JA, Christen R, Barton RM, Los G, Howell SB,. 1994. Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. Br J Cancer 70: 1102-1106.
11. Goyeneche AA, Caron RW, Telleria CM,. 2007. Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo. Clin Cancer Res 13: 3370-3379.
12. Guyton KZ, Xu Q, Holbrook NJ,. 1996. Induction of the mammalian stress response gene GADD153 by oxidative stress: Role of AP-1 element. Biochem J 314 (Pt 2): 547-554.
13. Heikinheimo O, Lahteenmaki PL, Koivunen E, Shoupe D, Croxatto H, Luukkainen T, Lahteenmaki P,. 1987. Metabolism and serum binding of RU 486 in women after various single doses. Hum Reprod 2: 379-385.
14. Huang J, Zhang Y, Huang Y, Zhang X, Xiao J,. 2010. [Reversal effect of mifepristone on adriamycin resistance in human breast cancer cell line MCF-7/ADM in vitro and in vivo]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35: 576-583.
15. Jang JH, Woo SM, Um HJ, Park EJ, Min KJ, Lee TJ, Kim SH, Choi YH, Kwon TK,. 2013. RU486, a glucocorticoid receptor antagonist, induces apoptosis in U937 human lymphoma cells through reduction in mitochondrial membrane potential and activation of p38 MAPK. Oncol Rep 30: 506-512.
16. Jiang J, Wu RF, Wang ZH, Sun HC, Xu Z, Xiu HM,. 2002. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro. Fertil Steril 77: 995-1000.
17. Jousse C, Bruhat A, Harding HP, Ferrara M, Ron D, Fafournoux P,. 1999. Amino acid limitation regulates CHOP expression through a specific pathway independent of the unfolded protein response. FEBS Lett 448: 211-216.
18. Jurado R, Lopez-Flores A, Alvarez A, Garcia-Lopez P,. 2009. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: An in vitro and in vivo study. Oncol Rep 22: 1237-1245.
19. Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH,. 2004. Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 in vitro and in vivo. World J Gastroenterol 10: 1726-1729.
20. Luethy JD, Holbrook NJ,. 1992. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 52: 5-10.
21. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D,. 2004. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18: 3066-3077.
22. Min KJ, Jang JH, Lee JT, Choi KS, Kwon TK,. 2012. Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2. J Mol Med (Berl) 90: 309-319.
23. Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM,. 2008. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol 62: 483-489.
24. Oyadomari S, Mori M,. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389.
25. Sanchez-Lopez E, Zimmerman T, Gomez del Pulgar T, Moyer MP, Lacal Sanjuan JC, Cebrian A,. 2013. Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells. Cell Death Dis 4: e933.
26. Skor MN, Wonder EL, Kocherginsky M, Goyal A, Hall BA, Cai Y, Conzen SD,. 2013. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res 19: 6163-6172.
27. Spitz IM, Grunberg SM, Chabbert- Buffet N, Lindenberg T, Gelber H, Sitruk- Ware R,. 2005. Management of patients receiving long-term treatment with mifepristone. Fertil Steril 84: 1719-1726.
28. Ubeda M, Habener JF,. 2000. CHOP gene expression in response to endoplasmic-reticular stress requires NFY interaction with different domains of a conserved DNA-binding element. Nucleic Acids Res 28: 4987-4997.
29. Wang XZ, Ron D,. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 272: 1347-1349.
30. Woo KJ, Lee TJ, Lee SH, Lee JM, Seo JH, Jeong YJ, Park JW, Kwon TK,. 2007. Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells. Biochem Pharmacol 73: 68-76.
31. Xu C, Bailly- Maitre B, Reed JC,. 2005. Endoplasmic reticulum stress: Cell life and death decisions. J Clin Invest 115: 2656-2664.
32. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K., 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891.